Search by Drug Name or NDC

    NDC 61703-0350-10 Methotrexate 25 mg/mL Details

    Methotrexate 25 mg/mL

    Methotrexate is a INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is METHOTREXATE SODIUM.

    Product Information

    NDC 61703-0350
    Product ID 61703-350_a70fd689-9446-44cc-bd40-77c997b50258
    Associated GPIs 21300050102062
    GCN Sequence Number 008798
    GCN Sequence Number Description methotrexate sodium VIAL 25 MG/ML INJECTION
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 38466
    HICL Sequence Number 003905
    HICL Sequence Number Description METHOTREXATE SODIUM
    Brand/Generic Generic
    Proprietary Name Methotrexate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Methotrexate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 25
    Active Ingredient Units mg/mL
    Substance Name METHOTREXATE SODIUM
    Labeler Name Hospira, Inc.
    Pharmaceutical Class Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA011719
    Listing Certified Through 2025-12-31

    Package

    NDC 61703-0350-10 (61703035010)

    NDC Package Code 61703-350-10
    Billing NDC 61703035010
    Package 5 VIAL, MULTI-DOSE in 1 CARTON (61703-350-10) / 2 mL in 1 VIAL, MULTI-DOSE (61703-350-09)
    Marketing Start Date 2014-09-25
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 3.19576
    Pricing Unit ML
    Effective Date 2022-11-23
    NDC Description METHOTREXATE 50 MG/2 ML VIAL
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5, 6
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis